Chartwell Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $23M | Sell |
116,490
-9,238
| -7% | -$1.72M | 0.79% | 16 |
|
|
2024
Q2 | $21.6M | Buy |
125,728
+16,340
| +15% | +$2.71M | 0.76% | 19 |
|
|
2024
Q1 | $19.9M | Sell |
109,388
-14,704
| -12% | -$2.53M | 0.69% | 22 |
|
|
2023
Q4 | $19.2M | Sell |
124,092
-2,556
| -2% | -$373K | 0.67% | 19 |
|
|
2023
Q3 | $18.9M | Sell |
126,648
-2,814
| -2% | -$413K | 0.73% | 16 |
|
|
2023
Q2 | $17.4M | Sell |
129,462
-2,365
| -2% | -$347K | 0.63% | 21 |
|
|
2023
Q1 | $21M | Buy |
131,827
+5,376
| +4% | +$822K | 0.8% | 15 |
|
|
2022
Q4 | $20.4M | Buy |
126,451
+14,949
| +13% | +$2.29M | 0.81% | 12 |
|
|
2022
Q3 | $15M | Buy |
111,502
+12,731
| +13% | +$1.83M | 0.64% | 26 |
|
|
2022
Q2 | $15.1M | Buy |
98,771
+13,002
| +15% | +$1.99M | 0.61% | 26 |
|
|
2022
Q1 | $13.9M | Sell |
85,769
-13,801
| -14% | -$2M | 0.46% | 60 |
|
|
2021
Q4 | $13.5M | Buy |
99,570
+42,985
| +76% | +$5.08M | 0.39% | 89 |
|
|
2021
Q3 | $6.1M | Sell |
56,585
-52
| -0.1% | -$5.94K | 0.19% | 192 |
|
|
2021
Q2 | $6.38M | Buy |
+56,637
| New | +$6.38M | 0.19% | 183 |
|
|
2019
Q2 | – | Sell |
-46,189
| Closed | -$3.72M | – | 408 |
|
|
2019
Q1 | $3.72M | Buy |
46,189
+2,025
| +5% | +$166K | 0.12% | 238 |
|
|
2018
Q4 | $4.07M | Sell |
44,164
-25,214
| -36% | -$2.22M | 0.14% | 215 |
|
|
2018
Q3 | $6.56M | Sell |
69,378
-2,195
| -3% | -$208K | 0.19% | 175 |
|
|
2018
Q2 | $6.63M | Buy |
71,573
+37,308
| +109% | +$3.64M | 0.2% | 170 |
|
|
2018
Q1 | $3.24M | Hold |
34,265
| – | – | 0.11% | 231 |
|
|
2017
Q4 | $3.31M | Hold |
34,265
| – | – | 0.11% | 266 |
|
|
2017
Q3 | $3.04M | Buy |
34,265
+450
| +1% | +$34.3K | 0.1% | 261 |
|
|
2017
Q2 | $2.45M | Hold |
33,815
| – | – | 0.09% | 263 |
|
|
2017
Q1 | $2.2M | Buy |
33,815
+4,010
| +13% | +$252K | 0.08% | 277 |
|
|
2016
Q4 | $1.87M | Sell |
29,805
-17,605
| -37% | -$1.07M | 0.06% | 321 |
|
|
2016
Q3 | $2.99M | Hold |
47,410
| – | – | 0.05% | 315 |
|
|
2016
Q2 | $2.94M | Sell |
47,410
-1,475
| -3% | -$89.9K | 0.05% | 296 |
|
|
2016
Q1 | $2.79M | Hold |
48,885
| – | – | 0.05% | 251 |
|
|
2015
Q4 | $2.9M | Buy |
48,885
+8,955
| +22% | +$516K | 0.06% | 252 |
|
|
2015
Q3 | $2.17M | Sell |
39,930
-2,275
| -5% | -$148K | 0.05% | 265 |
|
|
2015
Q2 | $2.83M | Buy |
42,205
+4,300
| +11% | +$281K | 0.06% | 265 |
|
|
2015
Q1 | $2.22M | Buy |
37,905
+4,655
| +14% | +$281K | 0.04% | 277 |
|
|
2014
Q4 | $2.18M | Buy |
33,250
+3,025
| +10% | +$191K | 0.05% | 309 |
|
|
2014
Q3 | $1.75M | Buy |
30,225
+13,125
| +77% | +$729K | 0.04% | 304 |
|
|
2014
Q2 | $965K | Buy |
+17,100
| New | +$897K | 0.02% | 317 |
|
Other funds holding ABBV
Chartwell Investment Partners's ABBV Position: Q3 2024 in Review
Chartwell Investment Partners reduced its AbbVie (ABBV) stake by 7.3% in Q3 2024, selling an estimated $1.72M and leaving 116,490 shares worth $23M. The position accounts for 0.79% of the portfolio, ranked #16.
Chartwell Investment Partners first reported a position in ABBV in Q2 2014 and has held it in 34 quarters since. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- Chartwell Investment Partners held 116,490 shares of AbbVie worth $23M as of Q3 2024.
- Chartwell Investment Partners sold 9,238 AbbVie shares in Q3 2024, an estimated $1.72M.
- AbbVie made up 0.79% of Chartwell Investment Partners's portfolio in Q3 2024, its #16 holding.
- Chartwell Investment Partners first reported a position in AbbVie in Q2 2014 and has held it in 34 quarters since.
- 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.